Zheman Xiao Selected Research

Major Depressive Disorder (Major Depressive Disorders)

1/2013	Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder.
1/2013	PDLIM5 gene polymorphisms and short term antidepressant response in Chinese major depressive disorders.
1/2011	Interaction between CRHR1 and BDNF genes increases the risk of recurrent major depressive disorder in Chinese population.
3/2007	Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheman Xiao Research Topics

Disease

17	Migraine Disorders (Migraine) 12/2023 - 07/2013
5	Headache (Headaches) 03/2024 - 01/2015
5	Pain (Aches) 01/2023 - 01/2015
4	Epilepsy (Aura) 10/2022 - 01/2017
4	Guillain-Barre Syndrome 02/2022 - 01/2018
4	Major Depressive Disorder (Major Depressive Disorders) 01/2013 - 03/2007
3	Hyperalgesia 01/2023 - 04/2022
2	Nausea 08/2023 - 01/2023
1	Body Weight (Weight, Body) 03/2024
1	Secondary Headache Disorders 12/2023
1	Vomiting 08/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2023
1	Heart Diseases (Heart Disease) 06/2023
1	AIDS-Related Complex (ARC) 02/2023
1	Photophobia (Light Sensitivity) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Hyperacusis (Phonophobia) 01/2023
1	Seizures (Absence Seizure) 04/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 04/2022
1	Diabetes Mellitus 02/2022
1	Cancer Pain 12/2020
1	Experimental Autoimmune Neuritis 12/2019
1	Cognitive Dysfunction 05/2019
1	Leukoencephalopathies 05/2019
1	Muscular Diseases (Myopathy) 05/2019
1	Febrile Seizures (Febrile Seizure) 10/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Infections 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Miller Fisher Syndrome (Fisher Syndrome) 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018

Drug/Important Bio-Agent (IBA)

5	Nitroglycerin (Dynamite)FDA LinkGeneric 08/2023 - 01/2023
4	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2018
3	Peptides (Polypeptides)IBA 06/2023 - 01/2023
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2022 - 01/2011
3	Amantadine (Aman)FDA LinkGeneric 02/2022 - 01/2018
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 06/2023 - 01/2023
2	CytokinesIBA 01/2023 - 12/2019
2	AcidsIBA 01/2023 - 01/2018
2	Calcitonin Gene-Related PeptideIBA 01/2023 - 01/2017
2	Pilocarpine (Ocusert)FDA LinkGeneric 04/2022 - 01/2017
2	Corticotropin-Releasing HormoneIBA 01/2013 - 03/2007
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 03/2007
1	Complement C1q (C1q Complement)IBA 03/2024
1	eptinezumabIBA 12/2023
1	Saline SolutionIBA 08/2023
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 06/2023
1	Sirtuin 3IBA 06/2023
1	Therapeutic UsesIBA 06/2023
1	Memantine (Namenda)FDA Link 02/2023
1	Sumatriptan (Imigran)FDA LinkGeneric 02/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Tryptamines (Triptans)IBA 01/2023
1	Pyruvate KinaseIBA 01/2023
1	EnzymesIBA 01/2023
1	PhosphofructokinasesIBA 01/2023
1	EstersIBA 01/2023
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	HexokinaseIBA 01/2023
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2023
1	2-(nicotinamide)-1,3,4-thiadiazoleIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023
1	Toll-Like Receptor 4IBA 10/2022
1	MuscimolIBA 10/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2022
1	Purinergic P2X7 ReceptorsIBA 07/2022
1	AZD8797IBA 04/2022
1	Lithium ChlorideIBA 04/2022
1	Chemokine CX3CL1IBA 04/2022
1	GlucocorticoidsIBA 02/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	Interleukin-18 (Interleukin 18)IBA 12/2020
1	Interleukin-17 (Interleukin 17)IBA 12/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018
1	SolutionsIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Transient Receptor Potential ChannelsIBA 01/2018
1	Amiloride (Midamor)FDA LinkGeneric 01/2018
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 01/2018
1	Acid Sensing Ion ChannelsIBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	syncytinIBA 01/2018
1	KN 93IBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015

Therapy/Procedure

3	Therapeutics 11/2023 - 01/2015
3	Intraperitoneal Injections 01/2023 - 04/2022
1	Renal Dialysis (Hemodialysis) 03/2024
1	Precision Medicine 11/2023
1	Duration of Therapy 10/2022
1	Injections 04/2022
1	Artificial Respiration (Mechanical Ventilation) 02/2022
1	Length of Stay 01/2018